Pandemic influenza A vaccination and incidence of Guillain-Barre syndrome in Korea

被引:15
作者
Kim, Changsoo [1 ]
Rhie, Seonkyeong [2 ]
Suh, Mina [3 ]
Kang, Dae Ryong [4 ]
Choi, Yoon Jung [5 ]
Bae, Geun-Ryang [6 ]
Choi, Young-Chul [7 ]
Jun, Byung Yool [8 ]
Lee, Joon Soo [9 ]
机构
[1] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea
[2] CHA Univ, CHA Bundang Med Ctr, Dept Pediat, Songnam, South Korea
[3] Natl Canc Ctr, Goyang, South Korea
[4] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul 120752, South Korea
[5] Hlth Insurance Review & Assessment Serv, Seoul, South Korea
[6] Korea Ctr Dis Control & Prevent, Osong, South Korea
[7] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Neurol, Seoul 120752, South Korea
[8] Yonsei Univ, Grad Sch Publ Hlth, Dept Int Hlth Sci, Seoul 120752, South Korea
[9] Yonsei Univ, Severance Childrens Hosp, Epilepsy Res Ctr, Coll Med,Dept Pediat, Seoul 120752, South Korea
关键词
Guillain-Barre syndrome; Influenza; Incidence rate; Vaccination; EVENTS FOLLOWING RECEIPT; 2009; H1N1; VACCINE; UNITED-STATES; IMMUNIZATION; SAFETY; RISK; SURVEILLANCE; CAMPYLOBACTER; ASSOCIATION; MORTALITY;
D O I
10.1016/j.vaccine.2015.02.035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Many studies have investigated the association between Guillain-Barre syndrome (GBS) and vaccinations during the influenza A H1N1 pandemic of 2009 (pH1N1). Based on a nationally representative sample, we estimated the incidence of GBS during the pandemic period in Korea. Materials and methods: All medical records of CBS cases were reviewed in 28 randomly selected hospitals during 2008-2010, and the number of CBS cases at the national level was extrapolated using emergency care utilization data. The CBS rate per 100,000 person-years was estimated in the reference and pandemic periods. Results: The incidence of CBS was 0.63 (95% CI: 0.37-0.89) per 100,000 person-years in the reference period and 0.87(0.49-1.26) in the pandemic period. During the vaccination season, the pandemic period CBS incidence rate was not significantly higher than the reference period incidence rate (rate ratio: 1.52; 0.99-2.32), but difference was observed among persons aged 20-34 years. Rate of CBS increased after pH1N1 vaccination compared to the reference period (1.46,1.26-1.68). Discussion: The incidence of CBS increased slightly but not significantly during the pandemic period, although pH1N1 vaccination increased the CBS rate. Therefore,, mass influenza vaccination programs should not be precluded on the basis of CBS. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1815 / 1823
页数:9
相关论文
共 41 条
[1]   Guillain-Barre syndrome - Incidence and mortality rates in US hospitals [J].
Alshekhlee, Amer ;
Hussain, Zulfiqar ;
Sultan, Badr ;
Katirji, Bashar .
NEUROLOGY, 2008, 70 (18) :1608-1613
[2]   Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines [J].
Black, Steven ;
Eskola, Juhani ;
Siegrist, Claire-Anne ;
Halsey, Neal ;
MacDonald, Noni ;
Law, Barbara ;
Miller, Elizabeth ;
Andrews, Nick ;
Stowe, Julia ;
Salmon, Daniel ;
Vannice, Kirsten ;
Izurieta, Hector S. ;
Akhtar, Aysha ;
Gold, Mike ;
Oselka, Gabriel ;
Zuber, Patrick ;
Pfeifer, Dina ;
Vellozzi, Claudia .
LANCET, 2009, 374 (9707) :2115-2122
[3]   Guillain-Barr, syndrome related to pandemic influenza A (H1N1) infection [J].
Chaari, Anis ;
Bahloul, Mabrouk ;
Dammak, Hassen ;
Nourhene, Gharbi ;
Rekik, Noureddine ;
Hedi, Chelly ;
Chokri, Ben Hamida ;
Bouaziz, Mounir .
INTENSIVE CARE MEDICINE, 2010, 36 (07) :1275-1275
[4]   Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010 [J].
Choe, Young June ;
Cho, Heeyeon ;
Kim, Sung Nam ;
Bae, Geun-Ryang ;
Lee, Jong-Koo .
VACCINE, 2011, 29 (44) :7727-7732
[5]   Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition [J].
Choe, Young June ;
Cho, Heeyeon ;
Bae, Geun-Ryang ;
Lee, Jong-Koo .
VACCINE, 2011, 29 (11) :2066-2070
[6]  
COE C J, 1989, Yonsei Medical Journal, V30, P81
[7]   Risk of Guillain-Barre Syndrome Following H1N1 Influenza Vaccination in Quebec [J].
De Wals, Philippe ;
Deceuninck, Genevieve ;
Toth, Eveline ;
Boulianne, Nicole ;
Brunet, Denis ;
Boucher, Renee-Myriam ;
Landry, Monique ;
De Serres, Gaston .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (02) :175-181
[8]   Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe [J].
Dieleman, Jeanne ;
Romio, Silvana ;
Johansen, Kari ;
Weibel, Daniel ;
Bonhoeffer, Jan ;
Sturkenboom, Miriam .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[9]   International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines [J].
Dodd, Caitlin N. ;
Romio, Silvana A. ;
Black, Steven ;
Vellozzi, Claudia ;
Andrews, Nick ;
Sturkenboom, Miriam ;
Zuber, Patrick ;
Hua, Wei ;
Bonhoeffer, Jan ;
Buttery, Jim ;
Crawford, Nigel ;
Deceuninck, Genevieve ;
de Vries, Corinne ;
De Wals, Philippe ;
Gutierrez-Gimeno, M. Victoria ;
Heijbel, Harald ;
Hughes, Hayley ;
Hur, Kwan ;
Hviid, Anders ;
Kelman, Jeffrey ;
Kilpi, Tehri ;
Chuang, S. K. ;
Macartney, Kristine ;
Rett, Melisa ;
Lopez-Callada, Vesta Richardson ;
Salmon, Daniel ;
Sanchez, Francisco Gimenez ;
Sanz, Nuria ;
Silverman, Barbara ;
Storsaeter, Jann ;
Thirugnanam, Umapathi ;
van der Maas, Nicoline ;
Yih, Katherine ;
Zhang, Tao ;
Izurieta, Hector .
VACCINE, 2013, 31 (40) :4448-4458
[10]   Risk of Confirmed Guillain-Barre Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009-2010 [J].
Greene, Sharon K. ;
Rett, Melisa ;
Weintraub, Eric S. ;
Li, Lingling ;
Yin, Ruihua ;
Amato, Anthony A. ;
Ho, Doreen T. ;
Sheikh, Sarah I. ;
Fireman, Bruce H. ;
Daley, Matthew F. ;
Belongia, Edward A. ;
Jacobsen, Steven J. ;
Baxter, Roger ;
Lieu, Tracy A. ;
Kulldorff, Martin ;
Vellozzi, Claudia ;
Lee, Grace M. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 (11) :1100-1109